Role of somatic cancer mutations in human protein lysine methyltransferases.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2014-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbcan.2014.08.002PMID 25123655
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of functional cooperative mutations of SETD2 in human acute leukemia

  2014cited by this paper
• Mutations in epigenetic regulators including SETD2 are gained during relapse in pediatric acute lymphoblastic leukemia

  2014cited by this paper
• Targeting histone lysine demethylases — Progress, challenges, and the future

  2014cited by this paper
• Interpreting the language of histone and DNA modifications.

  2014cited by this paper
• SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer

  2014cited by this paper
• An unexpected journey: lysine methylation across the proteome.

  2014cited by this paper
• Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies

  2014cited by this paper
• A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers.

  2014cited by this paper
• SMYD2 is highly expressed in pediatric acute lymphoblastic leukemia and constitutes a bad prognostic factor.

  2014cited by this paper
• The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.

  2014cited by this paper
• The functional diversity of protein lysine methylation

  2014cited by this paper
• New concepts in DNA methylation.

  2014cited by this paper
• Substrate specificity analysis and novel substrates of the protein lysine methyltransferase NSD1.

  2014cited by this paper
• The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes

  2014cited by this paper
• A rationale to target the SWI/SNF complex for cancer therapy.

  2014cited by this paper
• Molecular basis for substrate recognition by lysine methyltransferases and demethylases.

  2014cited by this paper
• Protein methylation at the surface and buried deep: thinking outside the histone box.

  2013cited by this paper
• A double take on bivalent promoters.

  2013cited by this paper
• Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia

  2013cited by this paper
• A medicinal chemistry perspective for targeting histone H3 lysine-79 methyltransferase DOT1L.

  2013cited by this paper
• Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas

  2013cited by this paper
• Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia

  2013cited by this paper
• Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation

  2013cited by this paper
• Epigenetic Reprogramming in Cancer

  2013cited by this paper
• Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

  2013cited by this paper
• A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells.

  2013cited by this paper
• Emerging patterns of somatic mutations in cancer

  2013cited by this paper
• DNA methylation dynamics in health and disease

  2013cited by this paper
• Abrogation of MLL–AF10 and CALM–AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l

  2013cited by this paper
• Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases

  2012cited by this paper
• RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation.

  2012cited by this paper
• Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)

  2012cited by this paper
• Lysine methylation of VCP by a member of a novel human protein methyltransferase family

  2012cited by this paper
• A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells.

  2012cited by this paper
• Cancer epigenetics: from mechanism to therapy.

  2012cited by this paper
• Understanding the language of Lys36 methylation at histone H3

  2012cited by this paper
• PRC2 directly methylates GATA4 and represses its transcriptional activity.

  2012cited by this paper
• Histone methylation: a dynamic mark in health, disease and inheritance

  2012cited by this paper
• Cancer genetics and epigenetics: two sides of the same coin?

  2012cited by this paper
• The pathogenesis of mixed-lineage leukemia.

  2012cited by this paper
• Recurrent R-spondin fusions in colon cancer

  2012cited by this paper
• Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation

  2012cited by this paper
• EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex.

  2012cited by this paper
• Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma.

  2012cited by this paper
• Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

  2012cited by this paper
• SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.

  2012cited by this paper
• EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

  2012cited by this paper
• Histone Methylase MLL1 plays critical roles in tumor growth and angiogenesis and its knockdown suppresses tumor growth in vivo

  2012cited by this paper
• Cancers and the NSD family of histone lysine methyltransferases.

  2011cited by this paper
• Biochemical characterization of human SET and MYND domain-containing protein 2 methyltransferase.

  2011cited by this paper
• Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification.

  2011cited by this paper
• The Genetic Landscape of the Childhood Cancer Medulloblastoma

  2011cited by this paper
• The Polycomb complex PRC2 and its mark in life

  2011cited by this paper
• The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

  2011cited by this paper
• EZH2 Codon 641 Mutations are Common in BCL2-Rearranged Germinal Center B Cell Lymphomas

  2011cited by this paper
• The diverse functions of Dot1 and H3K79 methylation.

  2011cited by this paper
• NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.

  2011cited by this paper
• Unraveling the genetics of cancer: genome sequencing and beyond.

  2011cited by this paper
• Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3

  2011cited by this paper
• Specificity analysis-based identification of new methylation targets of the SET7/9 protein lysine methyltransferase.

  2011cited by this paper
• MMSET is highly expressed and associated with aggressiveness in neuroblastoma.

  2011cited by this paper
• Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.

  2011cited by this paper
• Structure and Function of Mammalian DNA Methyltransferases

  2011cited by this paper
• Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.

  2011cited by this paper
• Frequent Alteration of MLL3 Frameshift Mutations in Microsatellite Deficient Colorectal Cancer

  2011cited by this paper
• Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor.

  2011cited by this paper
• MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.

  2011cited by this paper
• A decade of exploring the cancer epigenome — biological and translational implications

  2011cited by this paper
• Epigenetics: Targeting leukemia on the DOT.

  2011cited by this paper
• Somatic Mutations of the Mixed-Lineage Leukemia 3 (MLL3) Gene in Primary Breast Cancers

  2011cited by this paper
• Regulation of chromatin by histone modifications

  2011cited by this paper
• Genetic Inactivation of the PRC2 Complex in T-Cell Acute Lymphoblastic Leukemia

  2011cited by this paper
• Deficiency of H3K79 Histone Methyltransferase Dot1-like Protein (DOT1L) Inhibits Cell Proliferation*

  2011cited by this paper
• Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function

  2010cited by this paper
• Chromatin structure and the inheritance of epigenetic information

  2010cited by this paper
• Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

  2010cited by this paper
• Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers

  2010cited by this paper
• MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites

  2010cited by this paper
• Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

  2010cited by this paper
• Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

  2010cited by this paper
• Evidence for a tumour suppressor function of SETD2 in human breast cancer: a new hypothesis.

  2010cited by this paper
• COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

  2010cited by this paper
• Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma.

  2010cited by this paper
• Molecular Signals of Epigenetic States

  2010cited by this paper
• Methylation of the Retinoblastoma Tumor Suppressor by SMYD2*

  2010cited by this paper
• Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification

  2010cited by this paper
• Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas

  2010cited by this paper
• Somatic mutation of EZH2 (Y641) in Follicular and Diffuse Large B-cell Lymphomas of Germinal Center Origin

  2010cited by this paper
• The histone methyltransferase, NSD2, enhances androgen receptor‐mediated transcription

  2009cited by this paper
• A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf–Hirschhorn syndrome

  2009cited by this paper
• MLL histone methylases in gene expression, hormone signaling and cell cycle.

  2009cited by this paper
• A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4

  2009cited by this paper
• The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters

  2009cited by this paper
• MLL5, a trithorax homolog, indirectly regulates H3K4 methylation, represses cyclin A2 expression, and promotes myogenic differentiation

  2009cited by this paper
• Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks.

  2009cited by this paper
• Identification of Smyd4 as a potential tumor suppressor gene involved in breast cancer development.

  2009cited by this paper
• Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma.

  2009cited by this paper
• Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

  2009cited by this paper
• Global Analysis of H3K4 Methylation Defines MLL Family Member Targets and Points to a Role for MLL1-Mediated H3K4 Methylation in the Regulation of Transcriptional Initiation by RNA Polymerase II

  2009cited by this paper
• Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation.

  2009cited by this paper

• Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis

  2024cites this paper
• Discovery of NSD2 non-histone substrates and design of a super-substrate

  2024cites this paper
• Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases

  2023cites this paper
• Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis

  2023cites this paper
• Charakterisierung der Substratspezifität von Protein-Methyltransferasen

  2023cites this paper
• The R736H cancer mutation in DNMT3A modulates the properties of the FF-subunit interface.

  2022cites this paper
• Parallel functional annotation of cancer-associated missense mutations in histone methyltransferases

  2022cites this paper
• Epigenetic enzyme mutations as mediators of anti-cancer drug resistance.

  2022cites this paper
• Mechanistic basis of the increased methylation activity of the SETD2 protein lysine methyltransferase towards a designed super-substrate peptide

  2022cites this paper
• Structure, Activity and Function of the Suv39h1 and Suv39h2 Protein Lysine Methyltransferases

  2021cites this paper
• The benzene hematotoxic and reactive metabolite 1,4-benzoquinone impairs the activity of the histone methyltransferase SETD2 and causes aberrant H3K36 trimethylation (H3K36me3)

  2021cites this paper
• The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma

  2021cites this paper
• The Benzene Hematotoxic and Reactive Metabolite 1,4-Benzoquinone Impairs the Activity of the Histone Methyltransferase SET Domain Containing 2 (SETD2) and Causes Aberrant Histone H3 Lysine 36 Trimethylation (H3K36me3)

  2021cites this paper
• NGS Analysis Confirms Common TP53 and RB1 Mutations, and Suggests MYC Amplification in Ocular Adnexal Sebaceous Carcinomas

  2021cites this paper
• Exploration of the Activation Mechanism of the Epigenetic Regulator MLL3: A QM/MM Study

  2021cites this paper
• Low H3K9me3 Expression Is Associated With Poor Prognosis in Patients With Distal Common Bile Duct Cancer

  2020cites this paper
• Sequence specificity analysis of the SETD2 protein lysine methyltransferase and discovery of a SETD2 super-substrate

  2020cites this paper
• The Role of Epigenetics and Non-coding RNAs in Autophagy: A new Perspective for Thorough Understanding.

  2020cites this paper
• Methylation of human elongation factor eEF1A2 is not essential for eEF1A2-eEF1B interaction

  2020cites this paper
• Somatic Cancer Mutations in the SUV420H1 Protein Lysine Methyltransferase Modulate its Catalytic Activity.

  2019cites this paper
• KMT2C Mutations in Diffuse-Type Gastric Adenocarcinoma Promote Epithelial-to-Mesenchymal Transition

  2018cites this paper
• The DNMT3A R882H mutant displays altered flanking sequence preferences

  2018cites this paper
• Muscle-Specific Histone H3K36 Dimethyltransferase SET-18 Shortens Lifespan of Caenorhabditis elegans by Repressing daf-16a Expression.

  2018cites this paper
• Crystallographic and Computational Characterization of Methyl Tetrel Bonding in S-Adenosylmethionine-Dependent Methyltransferases

  2018cites this paper
• Enzymatic characterization of protein lysine methyltransferases

  2017cites this paper
• Kinetic Analysis of the Inhibition of the NSD1, NSD2 and SETD2 Protein Lysine Methyltransferases by a K36M Oncohistone Peptide

  2017cites this paper
• Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5/RBBP5/ASH2L complex

  2017cites this paper
• Wolf-Hirschhorn syndrome candidate 1-like 1 epigenetically regulates nephrin gene expression.

  2017cites this paper
• SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis

  2017cites this paper
• Identification of SETD2-NF1 fusion gene in a pediatric spindle cell tumor with the chromosomal translocation t(3;17)(p21;q12)

  2017cites this paper
• Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy.

  2016cites this paper
• Investigation of H2AX methylation by the SUV39H2 protein lysine methyltransferase

  2016cites this paper
• Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia

  2016cites this paper
• Dysregulation of histone methyltransferases in breast cancer – Opportunities for new targeted therapies?

  2016influential citation
• Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations

  2016cites this paper
• Activity and specificity of the human SUV39H2 protein lysine methyltransferase.

  2015cites this paper
• Investigating telomerase regulation in human breast cancer cells: a search for telomerase repressor sequences localised to chromosome 3P

  2015cites this paper
• Histone methyltransferases: novel targets for tumor and developmental defects.

  2015cites this paper
• Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death

  2015cites this paper
• Somatic cancer mutations in the MLL3-SET domain alter the catalytic properties of the enzyme

  2015cites this paper
• Expanding the SRI domain family: A common scaffold for binding the phosphorylated C‐terminal domain of RNA polymerase II

  2014cites this paper
• Chromatin modification by the RNA Polymerase II elongation complex

  2014cites this paper
• Mutations in Histone Lysine Methyltransferases and Demethylases

  2014cites this paper